期刊文献+

PLK1稳定β-catenin 促进食管鳞癌细胞上皮间质转化 被引量:2

PLK1 promotes epithelial-mesenchymal transition of esophageal squamous cell carcinoma cells by stabilizing β-catenin
下载PDF
导出
摘要 目的研究PLK1(Polo-like kinase 1)对食管鳞癌细胞株TE-15上皮间质转化(epithelial-mesenchymal transition,EMT)的影响,并探讨其作用机制。方法 Western blot检测PLK1稳定过表达的食管鳞癌细胞克隆与空载对照克隆中EMT相关标志蛋白E-钙粘素(E-cadherin)、波形蛋白(vimentin)的表达情况;Real-time PCR检测vimentin mRNA表达水平;分别提取细胞总蛋白和胞核蛋白,Western blot检测PLK1对信号通路分子β-连环蛋白(β-catenin)表达的影响;采用RNA干扰技术,在PLK1过表达克隆中分别瞬时转染靶向β-catenin的siRNA和非特异性siRNA,Western blot检测细胞中vimentin的表达;通过免疫沉淀和Western blot检测PLK1对β-catenin降解复合物的影响。结果与空载对照克隆相比,PLK1过表达的食管鳞癌细胞中,间质标志物vimentin的表达明显上调,上皮标志物E-cadherin的表达明显下调,提示食管鳞癌细胞发生了EMT;vimentin mRNA表达水平亦明显升高;在PLK1过表达的克隆中,细胞总蛋白和胞核蛋白中β-catenin表达都明显增加,敲降β-catenin的表达能引起vimentin的表达下降;Axin免疫沉淀物中的APC及GSK-3β都明显减少。结论 PLK1可能通过抑制β-catenin降解复合物的聚合而稳定β-catenin,从而上调vimentin表达,促进食管鳞癌细胞TE-15发生EMT。 Aim To investigate the effect of PLK1 on epithelial-mesenchymal transition (EMT)of human e-sophageal squamous cell carcinoma (ESCC)cells TE-1 5 and its relevant molecular mechanisms.Methods PLK1 overexpressed ESCC cells and control vector were used as the experimental cells.The expression of EMT-related protein markers E-cadherin and vimentin were measured by Western blot.vimentin mRNA was measured by Real-time PCR.Total cellular protein and nuclear protein were respectively extracted,and then they were used to detect the expression of β-catenin by Western blot.β-catenin siRNA and non-specific siR-NA were transiently transfected into the cell clones overexpressed PLK1 ,and then vimentin was detected by Western blot.β-catenin protein degradation com-plex was detected by immunoprecipitation and Western blot.Results The mesenchymal marker vimentin was distinctively upregulated and the epithelial marker E-cadherin was distinctively downregulated in the cell clones overexpressed PLK1 ,compared with those in the vector clones.This indicated that EMT occurred in ESCC cells.vimentin mRNA was also markedly in-creased.In the cell clones overexpressed PLK1 ,β-catenin were both elevated from the total cells and the nucleus.The expression of vimentin was reduced whenβ-catenin was knocked down.APC and GSK-3βwere both reduced from Axin immunoprecipitate in the cell clones overexpressed PLK1 .Conclusion PLK1 up-regulates vimentin and promotes EMT in ESCC cells probably by inhibiting the formation of protein degrada-tion complex and stabilizing β-catenin.
出处 《中国药理学通报》 CAS CSCD 北大核心 2014年第12期1748-1751,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 30901779) 山东省自然科学基金资助项目(No Y2008F15,ZR2009CM019,ZR2012CM025) 山东省高等学校科技计划项目(NoJ11LF67)
关键词 PLK1 食管鳞癌 RNA 干扰 vimentin EMT β-catenin esophageal squamous cell carcino-ma vimentin EMT β-catenin RNA interference
  • 相关文献

参考文献3

二级参考文献32

  • 1Liu X, Erikson RL. Activation of Cdc2/cyclin Band inhibition of centrosome amplification in cells de?pleted of Plk1 by siRNA. Proc Natl Acad Sci USA 2002; 99: 8672-8676 [PMID: 12077309].
  • 2Schmit TL, Nihal M, Ndiaye M, Setaluri V, Spiegel?man VS, Ahmad N. Numb regulates stability and localization of the mitotic kinase PLK1 and is re?quired for transit through mitosis. Cancer Res 2012; 72: 3864-3872 [PMID: 22593191].
  • 3Zhang L, Shao H, Huang Y, Yan F, Chu Y, Hou H, Zhu M, Fu C, Aikhionbare F, Fang G, Ding X, Yao X. PLK1 phosphorylates mitotic centromere-associated kinesin and promotes its depolymerase activity. I Bioi Chern 2011; 286: 3033-3046 [PMID: 21078677 DOl: 10.1074/jbc.M110.165340].
  • 4Beck J, Maerki S, Posch M, Metzger T, Persaud A, Scheel H, Hofmann K, Rotin D, Pedrioli P, Swedlow JR, Peter M, Sumara I. Ubiquitylation-dependent lo?calization of PLK1 in mitosis. Nat Cell Bioi 2013; 15: 430-439 [PMID: 23455478 DOl: 10.1038/ncb2695].
  • 5Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K, Kimura M, Okano Y, Saji S. Polo-like ki?nase 1 (PLK1) is overexpressed in primary colorec?tal cancers. Cancer Sci 2003; 94: 148-152 [PMID: 12708489].
  • 6Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamana?ka R, Miyakawa I. Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett 2001; 164: 41-49 [PMID: 11166914].
  • 7Strebhardt K, Kneisel L, Linhart C, Bernd A, Kaufmann R. Prognostic value of pololike kinase expression in melanomas. lAMA 2000; 283: 479-480 [PMID: 10659871].
  • 8Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Riibsamen?Waigmann H, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997; 14: 543-549 [PMID: 9053852].
  • 9Zhao C, Gong L, Li W, Chen L. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma. , Cancer Res Clin Oncol 2010; 136: 9-16 [PMID: 19572149 DOl: 10.1007/s00432-009-0630-4].
  • 10Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Fac?tors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases. Oncol Lett 2013; 5: 185-190 [PMID: 23255917].

共引文献23

同被引文献4

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部